Not surprisingly, SHP2 suppressed the proliferation of esophageal squamous cell cancer by inhibiting STAT3 phosphorylation, and depletion of SHP2 resulted in the attenuation of cisplatin sensitivity [82]. The gene discussed is STAT3; the disease is esophageal squamous cell carcinoma.